Research Article | Volume 11, Issue 1, January, 2023

Multitargeted molecular docking study of phytochemicals on hepatocellular carcinoma

Vikas Jha Anjali Bhosale Prakruti Kapadia Agraj Bhargava Arpita Marick Zahra Charania Omkar Parulekar Mafiz Shaikh Bhakti Madaye   

Open Access   

Published:  Nov 22, 2022

DOI: 10.7324/JABB.2023.110117

Hepatocellular carcinoma (HCC) is the fourth major cause of death worldwide, with a global diminishing survival rate of 19%. Irrespective of the advanced therapeutic strategies against this carcinoma, it persists as one of the most challenging diseases. Moreover, the low efficacy of existing treatment stratagem using synthetic drugs against HCC has led to the urgent investigation of natural alternatives that can result in a more efficient treatment with fewer health side effects than their synthetic counterparts. In this study, a total of 1259 phytochemicals were docked against 25 potential HCC protein targets with the help of PyRx, a virtual screening tool software. The pharmacokinetics and drug-like properties of these chemicals were examined through SWISS ADME webserver. Based on their binding affinity against each protein target, only 250 ligands were shortlisted further for toxicity analysis using the web tools ADMETlab 2.0 and Protox II. In accordance with the bioavailability radar and pharmacokinetic profile analysis, only two non-toxic phytochemicals: Sorgolactone and Alectrol, emerged as the most befitting drug candidates against HCC protein targets 6HH1 and 1ZXM, respectively. The findings of this study suggest that these two phytochemicals can be explored and exploited further for their use as potential HCC drug candidates.

Keyword:     In silico Liver cancer Molecular docking Phytochemicals Toxicity


Jha V, Bhosale A, Kapadia P, Bhargava A, Marick A, Charania Z, Parulekar O, Shaikh M, Madaye B. Multitargeted molecular docking study of phytochemicals on hepatocellular carcinoma. J App Biol Biotech. 2023;11(1):116-130.

Copyright: Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

HTML Full Text

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 2021;71:209-49.

2. Global Health Estimates: Life Expectancy and Leading Causes of Death and Disability. Cause-specific Mortality, 2009-2019. Available from: [Last accessed on 2020 Apr]

3. Omran AR. The epidemiologic transition: A theory of the epidemiology of population change. Milbank Q 2005;83:731-57. 4. Gersten O, Wilmoth JR. The cancer transition in Japan since 1951. Demogr Res 2002;271-306.

5. American Cancer Society. American Cancer Society. Cancer Facts and Figures 2021. Atlanta: American Cancer Society; 2021. p. 1-72. Available from: [Last accessed on 2020 Apr]

6. Dasgupta P, Henshaw C, Youlden DR, Clark PJ, Aitken JF, Baade PD. Global trends in incidence rates of primary adult liver cancers: A systematic review and meta-analysis. Front Oncol 2020;10:1-17.

7. Howlader N, Noone AM, Krapcho M, Miller D, Brest A. SEER Cancer Statistics Review (CSR) 1975-2017. Available from: https:// [Last accessed on 2020 Apr]

8. Petrick JL, McGlynn KA. The changing epidemiology of primary liver cancer. Curr Epidemiol Rep 2019;6:104-11.

9. Suganya V, Anuradha V. In silico molecular docking of astaxanthin and sorafenib with different apoptotic proteins involved in hepatocellular carcinoma. Biocatal Agric Biotechnol 2019;19:101076.

10. Liver Cancer Types. Available from: cancer-types/liver-cancer/types [Last accessed on 2022 Apr 20].

11. Ambade A, Mandrekar P. Oxidative stress and inflammation: Essential partners in alcoholic liver disease. Int J Hepatol 2012;2012:853175.

12. Liu CY, Chen KF, Chen PJ. Treatment of liver cance. Cold Spring Harb Perspect Med 2015;5:a021535.

13. Da Rocha AB, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol 2001;1:364-9.

14. Cragg GM Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol 2005;100:72-9.

15. Pan L, Chai H, Kinghorn AD. The continuing search for antitumor agents from higher plants. Phytochem Lett 2010;3:1-8.

16. Pan L, Chai HB, Kingorn AD. Discovery of new anticancer agents from higher plants. Front Biosci (Schol Ed) 2012;4:142-56.

17. Sarkar B, Ullah MA, Islam SS, Rahman MH, Araf Y. Analysis of plant-derived phytochemicals as anti-cancer agents targeting cyclin dependent kinase-2, human topoisomerase IIa and vascular endothelial growth factor receptor-2. J Recept Signal Transduct Res 2021;41:217-33.

18. McConkey BJ, Sobolev V, Edelman M. The performance of current methods in ligand-protein docking. Curr Sci 2002;83:845-56.

19. Rashdan HR, El-Naggar M, Abdelmonsef AH. Synthesis, molecular docking studies and in silico admet screening of new heterocycles linked thiazole conjugates as potent anti-hepatic cancer agents. Molecules 2021;26:1705.

20. Sasidharan SP, Vasumathi AV. In vitro pharmacological, in vivo toxicological and in silico molecular docking analysis of glycopentalone, a novel compound from Glycosmis pentaphylla (Retz.) Correa. Med Chem Res 2017;26:1697-707.

21. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat YN, Weissig H, et al. The protein data bank. Nuclei Acids Res 2000;28:235-42.

22. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605-12.

23. Dallakyan S, Olson A. Small-molecule library screening by docking with pyrx. Glob Food Secur Gov 2015;1263:1-11.

24. Mohanraj K, Karthikeyan BS, Vivek-Ananth RP, Chand RP, Aparna SR, Mangalapandi P, et al. IMPPAT: A curated database of Indian medicinal plants, phytochemistry and therapeutics. Sci Rep 2018;8:4329.

25. Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, et al. ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 2021;49:W5-14.

26. Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 2018;46:W257-63.

27. Lin L, Yan L, Liu Y, Qu C, Ni J, Li H. The burden and trends of primary liver cancer caused by specific etiologies from 1990 to 2017 at the global, regional, National, age, and sex level results from the global burden of disease study 2017. Liver Cancer 2020;9:563-82.

28. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.

29. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012;142:1264-73.

30. Whitworth AL, Mann NH, Larkum AW. Serum microcystins level positively linked with risk of hepatocellular carcinoma: A case-control study in Southwest China. Ultrasound Obs Gynecol 2006;50:776-80.

31. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010;51:1972-8.

32. Varma AK, Patil R, Das S, Stanley A, Yadav L, Sudhakar A. Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS One 2010;5:e12029.

33. Munir A, Azam S, Mehmood A. Structure-based pharmacophore modeling, virtual screening and molecular docking for the treatment of ESR1 mutations in breast cancer. Drug Des Open Access 2016;5:1000137.

34. Pollastri MP. Overview on the rule of five. Curr Protoc Pharmacol 2010;9:9-12.

35. Bojarska J, Remko M, Breza M, Madura ID, Kaczmarek K, Zabrocki J, et al. A supramolecular approach to structure-based design with a focus on synthons hierarchy in ornithine-derived ligands: Review, synthesis, experimental and in silico studies. Molecules 2020;25:1135.

36. Waring MJ. Lipophilicity in drug discovery. Expert Opin Drug Discov 2010;5:235-48.

37. Bürger M Chory J. In-silico analysis of the strigolactone ligand-receptor system. Plant Direct 2020;4:e00263.

38. Bhoi A, Yadu B, Chandra J, Keshavkant S. Contribution of strigolactone in plant physiology, hormonal interaction and abiotic stresses. Planta 2021;254:28.

39. Bouwmeester H, Li C, Thiombiano B, Rahimi M, Dong L. Adaptation of the parasitic plant lifecycle: Germination is controlled by essential host signaling molecules. Plant Physiol 2021;185:1292-308.

40. Hasan MN, Razvi S, Kuerban A, Balamash KS, Al-Bishri WM, Abulnaja KO, et al. Strigolactones a novel class of phytohormones as anti-cancer agents. J Pestic Sci 2018;43:168-72

41. Prandi C, Kapulnik Y, Koltai H. Strigolactones: Phytohormones with promising biomedical applications. Eur J Org Chem 2021;2021:4019-26.

Article Metrics

0 Absract views 25 PDF Downloads 25 Total views

Related Search

By author names

Citiaion Alert By Google Scholar

Similar Articles

Predicted interaction of human Ribosomal Protein S15 with Fragile X Mental Retardation Protein

Edmund Ui-Hang Sim, Xiang-Ru Ma, Stella Li-Li Chan, Choon-Weng Lee, Kumaran Narayanan

Antibacterial potential of Caesalpinia bonducella extracts and their isolated phytoconstituents: in vitro and in silico analysis

S R Santosh Kumar, Sudhesh L Shastri, Venkatesh R, K Pradeepa, V Krishna

Molecular docking and its application in search of antisickling agent from Carica papaya

Dibya Ranjan Das, Dhanesh Kumar, Pravind Kumar, Bisnu Prasad Dash

In silico perceptions in structural elucidation of Exo-ß-1,4-glucanase and Endo-ß-1,3-glucanase from Streptomyces spp.

Lekshmi K. Edison, S. R. Reji, N. S. Pradeep

Virtual screening for novel inhibitors of human Histone Deacetylase 6: Promising new leads for Oral Squamous Cell Carcinoma

Sandhya Vijayasarathy, Jhinuk Chatterjee

Ab-initio modelling and docking evaluation of geographically derived coat proteins of chilli leaf curl virus with flavonoids and chemical compounds

Gnanaprakash Jeyaraj, Habeeb Shaik Mohideen, A. Swapna Geetanjali

Biochemical evaluation and molecular docking studies on encapsulated astaxanthin for the growth inhibition of Mycobacterium tuberculosis

Suganya Vasudevan, Anuradha Venkatraman, Syed Ali Mohammed Yahoob, Sasirekha, Malathi Jojula, Ravikumar Sundaram, P Boomi

Atherosclerotic plaque regression and HMG-CoA reductase inhibition potential of curcumin: An integrative omics and in-vivo study

Priyanka Riyad, Ashok Purohit, Karishma Sen, Heera Ram

Identification of phytocompounds from Paris polyphylla Smith as potential inhibitors against two breast cancer receptors (ERÞ and EGFR tyrosine kinase) through chromatographic and In silico approaches

Debmalya Das Gupta, Saurov Mahanta, Sasti Gopal Das, Sanjib Kumar Das, Dipayan Paul, Hui Tag, Pallabi Kalita Hui

Phytochemical analysis, antimicrobial and antioxidant activities of Aidia borneensis leaf extracts

Zulhamizan Awang-Jamil, Aida Maryam Basri, Norhayati Ahmad, Hussein Taha

Antimicrobial activity of the lichens Parmotrema andium and Dirinaria applanata

Bijayananda Sahoo, Satyabrata Dash, Sabyasachy Parida, Jayanta Kumar Sahu, Biswajit Rath

In vitro evaluation of the antibacterial potential of flavonoid glycosides from Glinus oppositifolius (L.) Aug. DC.

K. Suresh Kannan, D. Kandavel, P. Rajalakshmi, P. Maheswari

In silico studies of viral protein inhibitors of Marburg virus using phytochemicals from Andrographis paniculata

Ragupathy Hariprasath, Chandrasekar Akashpriya, Vasantha Veerappa Lakshmaiah, Nagella Praveen

Detrimental effects of microplastics in aquatic fauna on marine and freshwater environments – A comprehensive review

Irene Monica Jaikumar, Majesh Tomson, Manikantan Pappuswamy, Krishnakumar V, Anushka Shitut, Arun Meyyazhagan, Balamuralikrishnan Balasubramnaian, Vijaya Anand Arumugam